Atossa Therapeutics issues Series A/B common stock purchase warrants dated June 12, 2026
Atossa Therapeutics has issued common stock purchase warrants exercisable beginning December 12, 2026, with terms defined in a June 10, 2026 Securities Purchase Agreement. The warrants allow holders to purchase company common stock at specified exercise prices through termination
View filing at SEC.gov →